ABSTRACTS

O.03 Identification of candidate breast cancer predisposition genes by sequencing extended panel of 492 cancer associated genes in BRCA1/2 negative probands

BJMO - 2017, issue 3, february 2017

R.B. Shahi MSc, B. Caljon , S. De Brakeleer PhD, L. Decoster MD, PhD, C. Fontaine MD, L. Vanacker MD, M. Vanhoeij , I. Pauwels , M-L. Bonduelle , S. Van Dooren PhD, D. Croes , E. Teugels PhD, J. De Grève MD, PhD

Read more

O.04 Type II RAF inhibition causes superior ERK suppression compared to type I RAF inhibition in different BRAF mutant types recurrently found in lung cancer

BJMO - 2017, issue 3, february 2017

A. Noeparast PhD, P. Giron PhD, S. De Brakeleer PhD, U. De Ridder , E. Teugels PhD, J. De Grève MD, PhD

Read more

O.05 Clinical significance of CD73 expression in triple-negative breast cancer from the BIG 02-98 adjuvant phase III clinical trial

BJMO - 2017, issue 3, february 2017

L. Buisseret MD, S. Pommey , B. Allard , S. Garaud , M-A. Bergeron , I. Cousineau , L. Ameye , G. Chouinard , H. Duvillier , M. Paesmans , M.J. Piccart-Gebhart MD, K. Willard-Gallo , C. Sotiriou MD, PhD, J. Stagg

Read more

O.07 Mutational Landscaping of Liver Metastases with Desmoplastic and Replacement Growth Patterns

BJMO - 2017, issue 3, february 2017

P-J. Van Dam MD, B. Galjart , P. De Paepe MD, PhD, T. Feryn , V. Duwel , L. Dirix MD, P. Vermeulen MD, S. Van Laere PhD

Read more

O.08 Evaluation of HER2 expression and amplification in CTCs using CellSearch immunofluorescence and FISH

BJMO - 2017, issue 3, february 2017

A. Brouwer , P-J. Van Dam MD, E. Sluydts , M. Peeters MD, PhD, P. Vermeulen MD, S. Van Laere PhD, L. Dirix MD

Read more

O.09 Geriatric assessment (GA)- guided interventions in older patients (pts) with cancer

BJMO - 2017, issue 3, february 2017

L. Decoster MD, PhD, C. Kenis PhD, MSc, J. Flamaing , P.R. Debruyne , I. De Groof , C. Focan MD, PhD, F. Cornélis MD, V. Verschaeve MD, K. Vanoverbeke , Y. Libert , S. Luce , N. Nols , H. van den Bulck , J.C. Goeminne MD, K. Geboers , J.P. Lobelle , M. Lycke , K. Milisen PhD, H. Wildiers MD, PhD, A. Baitar

Read more

O.10 USP13 as a novel co-target for EGFR targeted therapies in EGFR mutant non-small cell lung cancer

BJMO - 2017, issue 3, february 2017

P. Giron PhD, C. Eggermont , E. Teugels PhD, G. Gutierrez , J. De Grève MD, PhD

Read more